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Summary: A new isocratic HPLC method, employing electro-
chemical detection, is described for the determination of urinary
vanillylmandelic acid, 5-hydroxyindoleacetic acid and homova-
nillic acid. The main advantages of this technique are: simplicity,
simultaneous determination of all analytes, the absence of an
extraction procedure, isocratic elution and low cost. The diluted
urine is injected onto a CIS reversed phase column. The mobile
phase is potassium dihydrogenphosphate buffer containing 1-
heptanesulphonic acid, methanol and acetonitrile. The calibration
curves are linear from 0.1 to 50 mg/1; the precision data show
CV less than 2.36% for within-day assay and less than 2.72%
for day-to-day assays. The mean recoveries for supplemented
samples are 98.2 to 102.0% for vanillylmandelic acid, 99.6 to
103.9% for 5-hydroxyindoleacetic acid and 98.7 to 102.0% for
homovanillic acid. In comparisons of the present method with
Radjaipur's extraction method (Radjaipur M. et al., Eur J Clin
Chem Clin Biochem 1994; 32:609-13) the slopes for the three
analytes were nearly 1, and the confidence region of the in-
tercepts was close to 0. In conclusion the technique seems to
be suitable for routine determination of the three analytes, espe-
cially for mass screening purposes.
Introduction
Vanillylmandelic acid (4-hydroxy-3-methoxymandelic acid) and
homovanillic acid (4-hydroxy-3-methoxy-phenylacetic acid), the
major metabolites of catecholamines, and 5-hydroxyindoleacetic
acid (5-hydroxy-3-indoleacetic acid), metabolite of serotonin, are
often determined in urine for neurologic diagnosis and for moni-
toring the response to therapy in illnesses like phaeochromocy-
toma, neuroblastoma and carcinoid syndrome, respectively (1,2).
High-performance liquid Chromatographie (HPLC) methods for
vanillylmandelic acid, homovanillic acid and 5-hydroxyindole-
acetic acid have been reported, either without (3 — 13) or with
(14—24) simultaneous determination of all three analytes. Com-
bined analysis was proposed mainly for technical reasons, but
the molecular characteristics of these metabolites also conve-
niently enable their simultaneous determination in a single
HPLC run. However none of these techniques is totally free of
technical problems, and the time of operation and high cost are
still matters of concern. For instance many methods need an
extraction step or sample pretreatment (14—22, 24): some deter-
minations require gradient elution techniques and an excessive
time for regeneration of the column after each run (14, 17, 18,
23, 24); in addition, some of these methods employ time-con-
suming procedures and/or need instrumentation not always avail-
able in a clinical laboratory (15, 18—20).
In this work we describe our new simultaneous HPLC technique,
developed for an isocratic separation and quantitation of vanillyl-
mandelic acid, 5-hydroxyindoleacetic acid and homovanillic acid




Urine samples were collected early in the morning from adult vol-
unteers who did not consume walnuts, vegetable food, coffee, ba-
nanas and food containing vanilla after 1 p. m. of the previous day.
In assessing the reliability of our method we expressed the concen-
trations of these metabolites in μηιοΐ/ΐ, rather than μιηοΐ of com-
pound per g creatinine which is used in routine analyses (19). Urine
was stored at —20 °C after acidification with 6 mol/1 hydrochloric
acid to a pH of about 4. Under these conditions vanillylmandelic
acid, 5-hydroxyindoleacetic acid and homovanillic acid are stable
for at least four weeks (7).
Reagents
All reagents and chemicals were of analytical grade and were
purchased from Carlo Erba (Milan, Italy) except for vanillylmande-
lic acid, 5-hydroindoleacetic acid, homovanillic acid and 1-hep-
tanesulphonic acid which were from Sigma (St. Louis, MO, USA).
Methanol and water, both of HPLC grade, were obtained from
Merck (Darmstadt, Germany).
Apparatus
A model 116 Beckman (Palo Alto, CA, USA) pump, a Rheodyne
(Berkeley, CA, USA) Model 7125 injector and a HP 3395 Integ-
rator (Hewlett-Packard, Les Ulis, France) were used. We em-
ployed an ES A electrochemical detector Model 5110 Coulochem
(Environmental Sciences Assoc. Bedford, MA, USA) with a
Model 5011 analytical cell. Separation was carried out with a
Supelcosil LC 18 DB 150 X 4.6 mm i.d. column (3-μηι particle
size) fitted with a 20 X 4.6 mm guard column (both from
Supelco, Oakville, Canada).
Standards
A stock solution (500 mg/1 each of vanillylmandelic acid, 5-hydro-
xyindoleacetic acid and homovanillic acid) was prepared by dis-
solving 50 mg of each compound in mobile phase and adjusting
the volume to 100 ml. This was divided into several aliquots and
frozen at —20 °C; under these conditions the stock solution is sta-
ble for at least 4 weeks and the working standards were prepared
by diluting it with mobile phase.
Mobile phase
The mobile phase is a mixture of 990 ml of 35 mmol/1 potassium
dihydrogenphosphate buffer containing 100 mg/1 of 1-heptanesul-
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phonic acid as the ion-pair agent to reduce the interferences in the
analysis (20) and 5 ml of methanol and 5 ml of acetonitrile to
shorten the retention times; the pH of the solution was adjusted to
2.8 with phosphoric acid. Prior to use the phase was degassed and
filtered through a 0.45 μηι MF Millipore filter.
Samples
Intact urine (100 μΐ) was added to another tube containing 4.9 ml
of mobile phase; 100 μΐ of this vortexed mixture was immediately
injected into the Chromatograph. When the urine sample contained
insoluble impurities, the assay was performed using the supernatant
after centrifugation (200 g, 5 min).
High performance liquid chromatography conditions
Diluted sample (100 μΐ) was injected into the HPLC. The flow rate
for the isocratic elution was set at 1.0 ml/min and the column was
maintained at room temperature. Since 5-hydroxyindoleacetic acid
oxidizes much more easily than vanillylmandelic acid and homova-
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Fig. 1 Chromatograms of
(a) a normal urine sample containing 17.16 μηιοΙ/1 vanillylmande-
lic acid, 10.09 μιηοΐ/ΐ 5-hydroxyindoleacetic acid and 14.10 μηιοΐ/ΐ
homovanillic acid,
(b) a Quantitative Urine Normal Control (Lyphochek level I, Bio-
Rad Laboratories, Anaheim, CA, USA) containing 14.11 μηιοΐ/ΐ
vanillylmandelic acid, 27.20 μηιοΙ/1 5-hydroxyindoleacetic acid
and 15.03 μηιοΙ/1 homovanillic acid,
(c) a Quantitative Urine Abnormal Control (Lyphochek level II)
containing 62.92 μιηοΐ/ΐ vanillylmandelic acid, 156.18 μιηοΐ/ΐ 5-
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(d) a pathological urine sample containing 111.42 μτηοΐ/ΐ vanillyl-
mandelic acid, 11.77 μηιοΐ/ΐ 5-hydroxyindoleacetic acid and 18.72
μηιοΙ/1 homovanillic acid,
(e) a pathological urine sample containing 22.45 μπιοΐ/ΐ vanillyl-
mandelic acid, 422.3 μηιοΙ/1 5-hydroxyindoleacetic acid and 10.92
μηιοΙ/1 homovanillic acid,
(f) a pathological urine sample containing 13.42 μηιοΙ/1 vanillyl-
mandelic acid, 15.32 μιηοΐ/ΐ 5-hydroxyindoleacetic acid and
253.59 μηιοΙ/1 homovanillic acid.
See text for Chromatographie conditions.
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chemically with detector 1 operated at +0.12 Volt, detector 2 at
+ 0.45 Volt and the guard cell at + 0.12 Volt.
Determination of vanillylmandelic acid, homovanillic
acid and 5-hydroxyindoleacetic acid by an extraction
method
For the method comparison we analysed 30 urine samples using our
method and Radjaipur's extraction method (20). Vanillylmandelic
Acid, homovanillic acid and 5-hydroxyindoleacetic acid were ex-
tracted from urine samples using a cation exchange column (Phar-
macia-LKB Freiburg, Germany) to remove neutral, basic, weakly
acidic sample components and proteins. An aliquot of the eluate was
injected into an isocratic HPLC system (pump: model 116 Beckman,
Palo Alto, Ca, USA; injector: Model 7125, Rheodyne, Berkeley, CA,
USA; integrator: HP 3395, Hewlett-Packard, Les Ulis, France). The
samples were separated on a reversed phase column (Supelcosil LC
18 DB 150 X 4.6 mm i.d., Supelco, Oakville, Canada), detected
electrochemically (Detector ESA Coulochem Model 5100A) and
quantitatively evaluated with the help of the internal standards. The
subsequent procedural steps and the HPLC analysis were performed
according to Radjaipur (20).
Statistical analysis
Data are expressed as means, SD and CV. Passing & Bablok
(25) regression analysis was used for the comparison between
methods.
Results
Figure 1 shows typical chromatograms obtained by direct-injection
analysis of 100 μΐ of diluted sample. Good separation and baselines
Tab. 1 Precision data for within-day and day-to-day measurements of vanillylmandelic acid,
5-hydroxyindoleacetic acid and homovanillic acid.
















































Tab. 2 Recovery of the method.








































Quantity added: 5 mg/1 in normal urine pool, 20 mg/1 in pathological urine pool









Ο 10 20 30 40 SO 60 70
Vanillylmandelic acid (extracted) [μπιοΐ/l]
Ο 20 40 60 60 100 120
Homovanillic add (extracted) [μσιοΙ/Ι]
0 SO 100 ISO 200
5-Hydroxyindoleacetic acid
(extracted) [μπιοΙ/Ι]
Fig. 2 Methods comparison by Passing & Bablok regression analysis.
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Tab. 3 Comparison of the present method with the extraction
method for vanillylmandelic acid, 5-hydroxyindoleacetic acid and
homovanillic acid determinations in urine. Passing & Bablok re-
gression analysis in the form y = a + bx. The confidence interval
(n = 30) is in parenthesis.










with low background are observed in normal and pathological sam-
ples. As shown in the figure, about 35 min are required for the
elution of vanillylmandelic acid, 5-hydroxyindoleacetic acid and
homovanillic acid. The calibration curves for all compounds, pre-
pared with chemical standards, were linear in the range 0.1 to 50
mg/1 (r > 0.999) with a negligible bias. The results for within-day
(n = 10) and day-to-day precision (n = 5) are reported in table 1.
Coefficients of variation less than 2.36% for within-day and less
than 2.72% for day-to-day were obtained. Linearity was studied by
adding known amounts of the three acids (5, 10 and 20 mg/1) to
two human urine pool samples (normal and pathological levels) on
three different occasions. Results: vanillylmandelic acid r > 0.998,
5-hydroxyindoleacetic acid r > 0.997, homovanillic acid
r > 0.997. Detection limits were below 0.1 mg/1 for all three me-
tabolites at a signal-to-noise ratio of 3. Recovery was assessed from
replicate analysis (n = 5) for two days by adding 5 mg/1 and 20
mg/1 of vanillylmandelic acid, 5-hydroxyindoleacetic acid and ho-
movanillic acid to normal and pathological urine pool samples
respectively (tab. 2). Figure 2 reports the comparison between van-
illylmandelic acid, homovanillic acid and 5-hydroxyindoleacetic
acid concentrations calculated by the present method and by Rad-
jaipur's extraction method; the data of the regression analysis are
reported in table 3. The slopes of the three analytes were close to
1, and the confidence region of the intercepts were close to 0. Then
we evaluated potential interference from common urine constitu-
ents and drugs, which may be eluted close to the peaks of interest
(16), by adding known amounts of these to the urine samples. None
of the tested compounds (epinephrine, serotonin, vanillic acid, uric
acid, ascorbic acid, acetaminophen, Z--DOPA, carbi-DOPA and
acetylsalicylic acid) showed substantial interference with the deter-
mination of vanillylmandelic acid, homovanillic acid and 5-hydro-
xyindoleacetic acid, because they gave recoveries < 0.1% or no
peak at all.
Discussion
Clinical diagnosis of some neurological disorders needs precise,
rapid and simple determination of catecholamine metabolites and
5-hydroxyindoleacetic acid in urine. Low-cost methods are neces-
sary to satisfy the rising demand for mass screening in childhood
(26—30). In view of its analytical characteristics, our technique
could represent a new solution to these requests. The key advantage
of this method is the ability of ion-pair chromatography (heptane-
sulphonic acid is added in the mobile phase) to reduce interference
by a large number of compounds commonly observed in urine (20).
The use of ion-pair chromatography and the above mentioned
HPLC conditions resulted in clean peaks of these three substances;
the extraction step was avoided without losing precision, accuracy
and linearity. Although no interferences have been shown in our
study, we think that a further investigation of the influence of di-
etary components is needed to confirm its specificity. However the
combination of all these characteristics ensures good reliability. In
conclusion our HPLC method is very fast, easy and inexpensive
and requires an apparatus easily accessible to all clinical laborato-
ries equipped with HPLC instrumentation, and it is certainly useful
for routine determination and for mass screening for neurological
impairment.
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